Immunotherapy is a Helpful Tool in Fighting Cancer

An experienced biologist in White Plains, New York, Madhu Kumar has had many opportunities to contribute to cancer research. As a cancer researcher, Madhu Kumar has been significantly involved with studies involving immunotherapy for patients.

Immunotherapy aims to utilize a patient’s own immune system to fight cancer. Also called biotherapy or biologic therapy, immunotherapy can either be used on its own or in conjunction with other cancer treatments. Currently, certain types of cancer respond to this treatment better than others.

There are four common types of immunotherapy. First, monoclonal antibodies(MAbs) are man-made versions of proteins found in the immune system. These antibodies are designed to bind to and attack specific parts of cancer cells.

Immune checkpoint inhibiters are drugs that are designed to take the brakes off of the immune system, essentially allowing the body’s immune system to kill off harmful cancer cells.

Cancer vaccines are another immune-related treatment option. These treatments contain cancer-associated antigens and are meant to enhance the immune system’s response to tumor cells.

Finally, non-specific immunotherapies are often used concurrently with other treatment options. They are intended to give the entire immune system a boost, making it more effective as it fights cancer cells.

Side effects to immunotherapies can include pain, swelling, soreness, redness, or itchiness at the injection site. Sometimes, a patient may experience flu-like symptoms or a serious allergic reaction.